Role of toll-like receptor 7 (TLR7) in voluntary alcohol consumption

• Published in: Brain, behavior, and immunity behavior, and immunity, 2020-10, Vol.89, p.423-432
• Main Authors: Grantham, E.K., Warden, A.S., McCarthy, G.S., DaCosta, A., Mason, S., Blednov, Y., Mayfield, R.D., Harris, R.A.
• Format: Article
• Language: English
• Subjects: Alcohol Drinking; Alcoholism; Animals; Ethanol; Mice; Mice, Inbred C57BL; Toll-Like Receptor 7; Toll-Like Receptors
• ISSN: 0889-1591; 1090-2139
• DOI: 10.1016/j.bbi.2020.07.029

•TLR7 activation during drinking decreases alcohol consumption partially due to sickness response.•Repeated TLR7 activation prior to drinking increases alcohol consumption.•Acute TLR7 activation upregulates MyD88- and TRIF-dependent pathways across most brain regions.•Repeated TLR7 activation causes behavioral and molecular tolerance. Overactivation of neuroimmune signaling has been linked to excessive ethanol consumption. Toll-like receptors (TLRs) are a major component of innate immune signaling and initiate anti- and pro-inflammatory responses via intracellular signal transduction cascades. TLR7 is upregulated in post-mortem brain tissue from humans with alcohol use disorder (AUD) and animals with prior exposure to ethanol. Despite this evidence, the role of TLR7 in the regulation of voluntary ethanol consumption has not been studied. We test the hypothesis that TLR7 activation regulates voluntary ethanol drinking behavior by administering a TLR7 agonist (R848) during an intermittent access drinking procedure in mice. Acute activation of TLR7 reduced ethanol intake, preference, and total fluid intake due, at least in part, to an acute sickness response. However, chronic pre-treatment with R848 resulted in tolerance to the adverse effects of the drug and a subsequent increase in ethanol consumption. To determine the molecular machinery that mediates these behavioral changes, we evaluated gene expression after acute and chronic TLR7 activation. We found that acute TLR7 activation produces brain region specific changes in expression of immune pathway genes, whereas chronic TLR7 activation causes downregulation of TLRs and blunted cytokine induction, suggesting molecular tolerance. Our results demonstrate a novel role for TLR7 signaling in regulating voluntary ethanol consumption. Taken together, our findings suggest TLR7 may be a viable target for development of therapies to treat AUD.